Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MyoKardia Inc | 240,997 | reported | 29 Apr 2016 | tx 2+4,807 |
| Edgewise Therapeutics, Inc. | 24,175 | reported | 02 Jan 2026 | tx 10+140,623 |
| Eidos Therapeutics, Inc. | 0 | reported | 26 Jan 2021 | tx 45+74,382−610,909 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 473 | 0.00 USD | |
| 11 Nov 2025 | PURCHASE | Edgewise Therapeutics, Inc. | 10,700 | 18.64 USD | first after silence |
| 01 Oct 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 728 | 0.00 USD | |
| 01 Jul 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 858 | 0.00 USD | |
| 16 Jun 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 559 | 0.00 USD | |
| 10 Jun 2024 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 20,594 | 0.00 USD | deriv |
| 26 Dec 2023 | PURCHASE | Edgewise Therapeutics, Inc. | 10,857 | 9.30 USD | first after silence |
| 12 Jun 2023 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 22,123 | 0.00 USD | deriv |
| 03 Mar 2023 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 43,731 | 0.00 USD | deriv |
| 26 Jan 2021 | TENDER | Eidos Therapeutics, Inc. | 380,467 | — | |
| 28 Dec 2020 | GIFT | Eidos Therapeutics, Inc. | 500 | 0.00 USD | |
| 26 Jan 2021 | OTHER | Eidos Therapeutics, Inc. | 70,000 | — | deriv |
| 17 Sept 2020 | SALE | Eidos Therapeutics, Inc. | 5,767 | 50.16 USD | |
| 16 Sept 2020 | SALE | Eidos Therapeutics, Inc. | 3,122 | 50.16 USD | |
| 15 Sept 2020 | SALE | Eidos Therapeutics, Inc. | 1,000 | 50.06 USD | |
| 14 Sept 2020 | SALE | Eidos Therapeutics, Inc. | 111 | 50.00 USD | anomaly |
| 07 Jul 2020 | SALE | Eidos Therapeutics, Inc. | 5,000 | 50.00 USD | |
| 29 Jun 2020 | OTHER | Eidos Therapeutics, Inc. | 1,088 | 0.00 USD | |
| 01 Jun 2020 | GIFT | Eidos Therapeutics, Inc. | 1,020 | 0.00 USD | |
| 03 Jun 2020 | SALE | Eidos Therapeutics, Inc. | 5,000 | 50.00 USD | |
| 02 Jun 2020 | GIFT | Eidos Therapeutics, Inc. | 1,020 | 0.00 USD | |
| 31 May 2020 | GRANT_AWARD | Eidos Therapeutics, Inc. | 444 | 41.57 USD | |
| 28 May 2020 | SALE | Eidos Therapeutics, Inc. | 5,000 | 50.00 USD | |
| 24 Apr 2020 | SALE | Eidos Therapeutics, Inc. | 2,153 | 50.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 11 Nov 2025.